Skip to main content
. Author manuscript; available in PMC: 2019 Oct 8.
Published in final edited form as: Adv Exp Med Biol. 2019;1117:241–255. doi: 10.1007/978-981-13-3588-4_13

Figure 1.

Figure 1

Some impediments to the bioavailablity and systemic activity of antimicrobial peptides. Antimicrobial peptides must accumulate significantly on bacteria to have bactericidal activity. In the body, interactions with host cells and tissue, interactions with serum proteins and proteolytic degradation can decrease accumulation, and decrease activity.